Register Now

Forgotten Password?

Contract service agreement to build new facility in China

Companies: Takeda Pharmaceutical
Announcement date: Mar 23 2011
Deal value, US$m: n/d

Details

Announcement date: Mar 23 2011
Industry sectors: Bigpharma
Pharmaceutical
Technology types: Facilities
Deal components: Contract service
Geographic focus: Asia » China

Financials

Deal value, US$m: n/d

Termsheet

Takeda Pharma of Japan has signed an agreement with China Medical City in Taizhou.

The company’s China subsidiary will build facilities in CMC, including buildings for R&D, manufacturing and marketing of innovative drugs.

Press Release

Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Ups Commitment to China 3/23/2011

March 23, 2011 -- Takeda Pharma of Japan has signed an agreement with China Medical City in Taizhou. The company’s China subsidiary will build facilities in CMC, including buildings for R&D, manufacturing and marketing of innovative drugs. The company candidly admits it is playing catch-up in China. “We missed the boat several times in China,” said Yasuchika Hasegawa, President of Takeda, last year. “We are trying to catch the last boat.”

Filing Data

Not available.

Contract

Not available.